ABSTRACT
Time course of equilibrium and nonequilibrium sorption of carminomycin on carboxylic cation exchanger BDM-12 has been studied. Physicochemical requirements and limits of mobile phase flow rate are determined for the regular mode of preparative chromatography under the conditions of sharpening of the chromatographic zone.
Subject(s)
Carubicin/isolation & purification , Chromatography, Ion Exchange/methods , Time FactorsABSTRACT
A daunorubicin-blocked mutant strain RPM-5 derived from a new baumycin-producing Streptomyces sp. D788 accumulated a major precursor metabolite D788-1 (10-carboxyl-13-deoxocarminomycin) and nine minor metabolites in the culture broth. Five among them were new with a substituent at C-10 or the altered side chains at C-9. Isolation, purification and identification of all anthracycline metabolites produced by strain RPM-5 are described with their antitumor activities against L1210 cells.
Subject(s)
Antibiotics, Antineoplastic/isolation & purification , Antibiotics, Antineoplastic/pharmacology , Daunorubicin/analogs & derivatives , Streptomyces/chemistry , Animals , Antibiotics, Antineoplastic/chemistry , Carubicin/analogs & derivatives , Carubicin/chemistry , Carubicin/isolation & purification , Carubicin/pharmacology , DNA Replication/drug effects , DNA, Neoplasm/drug effects , Daunorubicin/biosynthesis , Daunorubicin/pharmacology , Fermentation , Leukemia L1210/drug therapy , Magnetic Resonance Spectroscopy , Mice , RNA, Neoplasm/drug effects , Streptomyces/drug effects , Tumor Cells, CulturedABSTRACT
A limited biosynthetic conversion of some known anthracyclinones using a specific daunorubicin-nonproducing mutant provided four new anthracycline antibiotics: 1-Hydroxy-10-methoxycarbonyl-13-deoxocarminomycin; 1-hydroxy-13-deoxocarminomycin; 1-hydroxyoxaunomycin and 6-deoxyoxaunomycin. Their isolation and purification from bioconversion broth, structural determination and antitumor activities against leukemic L1210 cells are described.
Subject(s)
Anthracyclines , Antibiotics, Antineoplastic/biosynthesis , Daunorubicin/metabolism , Streptomyces/metabolism , Animals , Antibiotics, Antineoplastic/isolation & purification , Antibiotics, Antineoplastic/metabolism , Antibiotics, Antineoplastic/pharmacology , Carubicin/analogs & derivatives , Carubicin/biosynthesis , Carubicin/isolation & purification , Chromatography, High Pressure Liquid , Chromatography, Thin Layer , DNA Replication/drug effects , Drug Screening Assays, Antitumor , Leukemia L1210/drug therapy , Magnetic Resonance Spectroscopy , Mice , Microbiological Techniques , Mutation , Naphthacenes/metabolism , Streptomyces/genetics , Tumor Cells, CulturedSubject(s)
Antibiotics, Antineoplastic/isolation & purification , Carubicin/isolation & purification , Daunorubicin/analogs & derivatives , Animals , Antibiotics, Antineoplastic/pharmacology , Carubicin/analogs & derivatives , Carubicin/pharmacology , Chemical Phenomena , Chemistry , Mice , Nocardia/metabolismABSTRACT
A three component system for separating a mixture of carminomycin, carminomycinone and 13-dihydrocarminomycinone by HPLC was developed. Spherisorb ODS Column, 4.6 X 250 mm, the particle size of 10 micron was used. The impact of the mobile phase composition, temperature during chromatography and buffer solution pH on the capacity factors K' for every of the above compounds was studied. For determining purity of carminomycin dosage forms the procedure with an external standard was applied. The procedure provides routine quantitative assay of carminomycin hydrochloride dosage forms.
Subject(s)
Carubicin/analysis , Daunorubicin/analogs & derivatives , Buffers , Carubicin/analogs & derivatives , Carubicin/isolation & purification , Chromatography, High Pressure Liquid/instrumentation , Chromatography, High Pressure Liquid/methods , Hydrogen-Ion ConcentrationSubject(s)
Antibiotics, Antineoplastic/isolation & purification , Carubicin/analogs & derivatives , Daunorubicin/analogs & derivatives , Animals , Antibiotics, Antineoplastic/therapeutic use , Carubicin/isolation & purification , Carubicin/therapeutic use , Chemical Phenomena , Chemistry , Leukemia L1210/drug therapy , MiceABSTRACT
A new antibiotic complex has been obtained from the cultures of an actinomycete, strain FA-1180, isolated from a soil sample collected at lake side of Biwa in Japan. On the basis of taxonomic studies the producing microorganism is designated as Actinomadura roseoviolacea var. biwakoensis nov. var. The antibiotic complex belongs to the class of anthracycline glycoside antibiotics. All components form deep red fine needles on crystallization; components are named rubeomycin A, A1, B and B1. These components exhibit activity against Gram-positive bacteria as well as Yoshida sarcoma cell in vitro. These components are also effective on P388 leukemia.